Chargement en cours...
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
BACKGROUND: Despite inducing a sustained increase in CD4+ T cell counts, intermittent recombinant IL-2 (rIL-2) therapy did not confer a better clinical outcome in HIV-infected patients enrolled in large phase III clinical trials ESPRIT and SILCAAT. Several hypotheses were evoked to explain these dis...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3499432/ https://ncbi.nlm.nih.gov/pubmed/23021024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-9-220 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|